SK282874B6 - Použitie alylamínov na výrobu liečiva na liečenie infekcie spôsobenej Helicobacter pylori - Google Patents

Použitie alylamínov na výrobu liečiva na liečenie infekcie spôsobenej Helicobacter pylori Download PDF

Info

Publication number
SK282874B6
SK282874B6 SK6-98A SK698A SK282874B6 SK 282874 B6 SK282874 B6 SK 282874B6 SK 698 A SK698 A SK 698A SK 282874 B6 SK282874 B6 SK 282874B6
Authority
SK
Slovakia
Prior art keywords
formula
treatment
compound
pylori infection
helicobacter pylori
Prior art date
Application number
SK6-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK698A3 (en
Inventor
Ivan James Dalton Lindley
Neil Stewart Ryder
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK698A3 publication Critical patent/SK698A3/sk
Publication of SK282874B6 publication Critical patent/SK282874B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
SK6-98A 1995-07-06 1996-07-05 Použitie alylamínov na výrobu liečiva na liečenie infekcie spôsobenej Helicobacter pylori SK282874B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9513750.1A GB9513750D0 (en) 1995-07-06 1995-07-06 Use of allylamines
PCT/EP1996/002970 WO1997002026A1 (en) 1995-07-06 1996-07-05 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases

Publications (2)

Publication Number Publication Date
SK698A3 SK698A3 (en) 1998-05-06
SK282874B6 true SK282874B6 (sk) 2003-01-09

Family

ID=10777201

Family Applications (1)

Application Number Title Priority Date Filing Date
SK6-98A SK282874B6 (sk) 1995-07-06 1996-07-05 Použitie alylamínov na výrobu liečiva na liečenie infekcie spôsobenej Helicobacter pylori

Country Status (27)

Country Link
US (1) US5935998A (zh)
EP (1) EP0863752B1 (zh)
JP (1) JP3680950B2 (zh)
KR (1) KR100425401B1 (zh)
CN (1) CN1204881C (zh)
AT (1) ATE232723T1 (zh)
AU (1) AU715270B2 (zh)
CA (1) CA2219678C (zh)
CY (1) CY2465B1 (zh)
CZ (1) CZ289440B6 (zh)
DE (1) DE69626301T2 (zh)
DK (1) DK0863752T3 (zh)
ES (1) ES2192608T3 (zh)
GB (1) GB9513750D0 (zh)
HK (1) HK1011527A1 (zh)
HU (1) HU224311B1 (zh)
IL (1) IL122853A (zh)
MX (1) MX9710093A (zh)
MY (1) MY132436A (zh)
NO (1) NO317496B1 (zh)
PL (1) PL187704B1 (zh)
RU (1) RU2193402C2 (zh)
SI (1) SI0863752T1 (zh)
SK (1) SK282874B6 (zh)
TW (1) TW522011B (zh)
WO (1) WO1997002026A1 (zh)
ZA (1) ZA965749B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
KR20030066186A (ko) * 2002-02-05 2003-08-09 한솔케미언스 주식회사 (ｅ)-터비나핀 또는 이의 염산염의 제조방법
KR100978717B1 (ko) * 2003-12-08 2010-08-30 씨펙스 파마슈티칼스, 인코포레이티드 인슐린 치료를 위한 약제 조성물 및 방법
RU2449805C1 (ru) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2716943C2 (de) * 1976-04-28 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
EP0000896B1 (en) * 1977-08-19 1982-10-13 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them
DE3020113A1 (de) * 1979-06-08 1980-12-18 Sandoz Ag 2-(1-naphthyl)piperidin-derivat, dessen herstellung sowie die verwendung als antimykotika
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
EP0024587B1 (en) * 1979-08-22 1984-11-14 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
DE4317449A1 (de) * 1993-05-19 1994-11-24 Asche Ag Arzneimittel zur Behandlung von Erkrankungen des Magen-Darm-Traktes

Also Published As

Publication number Publication date
HUP9802929A3 (en) 1999-10-28
IL122853A (en) 2001-04-30
AU6519596A (en) 1997-02-05
MY132436A (en) 2007-10-31
PL187704B1 (pl) 2004-09-30
CA2219678C (en) 2006-10-10
US5935998A (en) 1999-08-10
CA2219678A1 (en) 1997-01-23
CY2465B1 (en) 2005-06-03
NO975790L (no) 1997-12-09
GB9513750D0 (en) 1995-09-06
IL122853A0 (en) 1998-08-16
DE69626301T2 (de) 2003-10-16
CN1204881C (zh) 2005-06-08
EP0863752A1 (en) 1998-09-16
MX9710093A (es) 1998-03-31
HK1011527A1 (en) 1999-07-16
RU2193402C2 (ru) 2002-11-27
AU715270B2 (en) 2000-01-20
EP0863752B1 (en) 2003-02-19
ZA965749B (en) 1998-01-05
ATE232723T1 (de) 2003-03-15
NO317496B1 (no) 2004-11-08
TW522011B (en) 2003-03-01
DE69626301D1 (de) 2003-03-27
CZ289440B6 (cs) 2002-01-16
KR19990028725A (ko) 1999-04-15
CZ1798A3 (cs) 1998-03-18
SI0863752T1 (en) 2003-06-30
CN1189775A (zh) 1998-08-05
JPH11508580A (ja) 1999-07-27
ES2192608T3 (es) 2003-10-16
HU224311B1 (hu) 2005-07-28
WO1997002026A1 (en) 1997-01-23
HUP9802929A2 (hu) 1999-09-28
KR100425401B1 (ko) 2004-07-16
PL323305A1 (en) 1998-03-16
DK0863752T3 (da) 2003-04-22
NO975790D0 (no) 1997-12-09
JP3680950B2 (ja) 2005-08-10
SK698A3 (en) 1998-05-06

Similar Documents

Publication Publication Date Title
Raether et al. Nitroheterocyclic drugs with broad spectrum activity
Pons et al. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions
EP0533280B2 (en) Novel medical use for tachykinin antagonists
KR100197452B1 (ko) 구토 치료를 위한 nk-1 수용체 길항제 및 5ht3 수용체 길항제
EP0866691B1 (en) Sublingual and buccal administration of selegiline
US6329394B1 (en) Medical use for tachykinin antagonists
SK282874B6 (sk) Použitie alylamínov na výrobu liečiva na liečenie infekcie spôsobenej Helicobacter pylori
JP3593357B2 (ja) 抗菌剤
US6271256B1 (en) Methods for controlling gram negative bacteria in mammals with bicyclo spiroether compounds
CA1238576A (en) Synergistic pharmaceutical composition
WO1998013041A1 (en) Prophylaxis and treatment of intestinal tract fluid and electrolyte loss using histidine compositions
JPS615017A (ja) 抗潰瘍組成物
CA1174169A (en) Orally active tolciclate and tolnaftate
US4310541A (en) Method of treating giardiasis and trichomoniasis
US6380217B1 (en) Methods for controlling GGT-positive bacteria
KR20030048476A (ko) 조루 치료법
CN115515599A (zh) 化合物在真菌感染的治疗中的用途
WO2020027344A1 (en) Ch24h inhibitors for mdd use
JPH0812576A (ja) 抗ヘリコバクター・ピロリ剤
JPH0578249A (ja) ５−フルオロウラシル類により起こる嘔気・嘔吐の防止及び治療剤
JPH0899808A (ja) 抗菌剤
JP2000080031A (ja) 抗菌剤
JPH10231246A (ja) Ａｄｐ−リボシル化阻害剤

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20110705